News

The firm claims that the new supplement has been tested and recommended by doctors and research laboratories. The new supplement aims to improve the user’s health and energy

Pfizer’s new pharmaceutical manufacturing plant will be built at the Industrial Valley, King Abdullah Economic City, on the west coast of the Red Sea, north of Jeddah. The

The approval of the spray followed the validation of convincing pre-clinical and clinical data on the safety and effectiveness of the drug. It is said to reduce the

The registration, which was filed under InB: Hauser Pharmaceutical Services, will now allow the firm to immediately manufacture schedule II-V compounds. With the new DEA registration status CHO

ClinStar provides Phase I-IV clinical research trials and clinical development services to a wide range of pharmaceutical and biotechnology companies in the Russian Federation, Ukraine, Belarus and the

Taiho is seeking approval of TAS-102 for the indication of unresectable, advanced, recurrent colorectal cancer. The application is based on the results of a Phase II clinical trial

Both the firms, which have been working together since 2007, have created a lean supply chain, prior to which the pharmaceutical firm’s manufacturing plants operated independently and managed

In February 2012, IDT and SGI began to co-manufacture and commercialize small synthetic gene products up to 5 kb, while IDT has also launched its gBlocks Gene Fragments

Created using patent-pending Cunermuspir complex, the new supplement supports optimum neuromuscular health and provides energy. Cunermuspir Complex helps to improve the body’s ability to absorb copper to support